Search for Clinical Trial Results

Sponsored By

Myelofibrosis - 47 Studies Found

Status Study
Active, not recruiting Study Name: Phase-3 Double-Blind, Placebo-Controlled Study of Pomalidomide in Persons With Myeloproliferative-Neoplasm-Associated Myelofibrosis and RBC-Transfusion-Dependence Myelofibrosis and RBC-Transfusion-Dependence
Condition: Primary Myelofibrosis
Date: 2010-07-15
Interventions:
  • Drug: Pomalidomide 0.5 mg Poma
Completed Study Name: Ruxolitinib Phosphate and Chemotherapy Given Before and After Reduced Intensity Donor Stem Cell Transplant in Treating Patients With Myelofibrosis
Condition:
  • Primary Myelofibrosis
  • Secondary Myelofibr
    Date: 2016-09-26
    Interventions:
    • Procedure: Allogeneic Hematopoietic Stem Cell Transplantation

Completed Study Name: A Clinical Study of Ruxolitinib in Patients With Primary Myelofibrosis (PM), Post-polycythemia Vera (PV) Myelofibrosis, or Post-essential Thrombocythemia (ET) Myelofibrosis
Condition: Primary Myelofibrosis (MF)
Date: 2014-03-12
Interventions: Drug: Ruxolitinib
Recruiting Study Name: JAK Inhibitor Before Donor Stem Cell Transplant in Treating Patients With Primary or Secondary Myelofibrosis
Condition:
  • Primary Myelofibrosis
  • Secondary Myelofibr
    Date: 2014-09-12
    Interventions:
    • Procedure: Allogeneic Hematopoietic Stem Cell Transplantation

Completed Study Name: A Phase 2 Study With IPI-926 in Patients With Myelofibrosis
Condition:
  • Primary Myelofibrosis
  • Fibrosis, Bone Marrow

Date: 2011-06-09
Interventions: Drug: IPI-926 Single Arm study of oral IPI-926 at 160 mg, 130 mg or 110 mg daily, until progressive dise
Completed Study Name: Assessment of Labile Plasma Iron (LPI) in Myelodysplastic Syndromes (MDS) and Primary Myelofibrosis
Condition:
  • Myelodysplastic Syndrome
  • Primary Myelofibrosis

Date: 2011-01-18
Recruiting Study Name: Durvalumab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis
Condition:
  • Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase
  • Date: 2016-08-09
    Interventions:
    • Biological: Durvalumab Given I